73 related articles for article (PubMed ID: 23752483)
1. Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma.
Guevara-Canales JO; Morales-Vadillo R; Cava-Vergiú CE; Leite FP; Miranda Chaves Netto HD; Soares FA; Chaves Md
Braz Oral Res; 2013; 27(4):349-55. PubMed ID: 23752483
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoma of the oral cavity and the maxillofacial region: overall survival prognostic factors.
Guevara-Canales JO; Morales-Vadillo R; Sacsaquispe-Contreras SJ; Barrionuevo-Cornejo C; Montes-Gil J; Cava-Vergiú CE; Soares FA; Chaves-Netto HD; Chaves MD
Med Oral Patol Oral Cir Bucal; 2013 Jul; 18(4):e619-26. PubMed ID: 23722134
[TBL] [Abstract][Full Text] [Related]
3. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study.
Kolokotronis A; Konstantinou N; Christakis I; Papadimitriou P; Matiakis A; Zaraboukas T; Antoniades D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):303-10. PubMed ID: 15716836
[TBL] [Abstract][Full Text] [Related]
4. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A
J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY
Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
Morabito F; Gallamini A; Stelitano C; Callea V; Guglielmi C; Neri S; Lazzaro A; Orsucci L; Ilariucci F; Sacchi S; Vitolo U; Federico M
Cancer; 2004 Oct; 101(7):1601-8. PubMed ID: 15378507
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
8. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.
Larouche JF; Berger F; Chassagne-Clément C; Ffrench M; Callet-Bauchu E; Sebban C; Ghesquières H; Broussais-Guillaumot F; Salles G; Coiffier B
J Clin Oncol; 2010 Apr; 28(12):2094-100. PubMed ID: 20308668
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of localized diffuse large B-cell lymphoma in younger patients.
Møller MB; Christensen BE; Pedersen NT
Cancer; 2003 Aug; 98(3):516-21. PubMed ID: 12879468
[TBL] [Abstract][Full Text] [Related]
12. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
[TBL] [Abstract][Full Text] [Related]
13. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru.
Beltran BE; Castillo JJ; Morales D; de Mendoza FH; Quinones P; Miranda RN; Gallo A; Lopez-Ilasaca M; Butera JN; Sotomayor EM
Am J Hematol; 2011 Aug; 86(8):663-7. PubMed ID: 21761432
[TBL] [Abstract][Full Text] [Related]
14. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of oral diffuse large B-cell lymphoma, NOS: A systematic review.
Rodrigues-Fernandes CI; de Souza LL; Santos-Costa SFD; Pontes HAR; de Almeida OP; Vargas PA; Henao JR; Rahimi S; Brennan PA; Fonseca FP
J Oral Pathol Med; 2019 Mar; 48(3):185-191. PubMed ID: 30414287
[TBL] [Abstract][Full Text] [Related]
16. [Primary gastric lymphoma].
Barreda B F; Gómez P R; Quispe L D; Sánchez L J; Combe G J; Casanova M L; Celis Z J
Rev Gastroenterol Peru; 2004; 24(3):238-62. PubMed ID: 15483686
[TBL] [Abstract][Full Text] [Related]
17. Conditional survival of patients with diffuse large B-cell lymphoma.
Moller MB; Pedersen NT; Christensen BE
Cancer; 2006 May; 106(10):2165-70. PubMed ID: 16586498
[TBL] [Abstract][Full Text] [Related]
18. Survival to oral cancer. A study of clinical risk markers with independent prognostic value.
Varela-Centelles PI; Seoane J; Vázquez Fernández E; De La Cruz A; García Asenjo JA
Bull Group Int Rech Sci Stomatol Odontol; 2002; 44(2):46-51. PubMed ID: 12577522
[TBL] [Abstract][Full Text] [Related]
19. Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype.
Sato Y; Onishi N; Morito T; Takata K; Mizobuchi K; Nagatsuka H; Ichimura K; Tanaka T; Tamura M; Yoshino T
Cancer Sci; 2009 Jan; 100(1):42-6. PubMed ID: 19018759
[TBL] [Abstract][Full Text] [Related]
20. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
